Pressure-induced maturation of endothelial cells on newborn mouse carotid arteries. 2013

Sheila Flavahan, and Mansoor M Mozayan, and Isa Lindgren, and Nicholas A Flavahan
Department of Anesthesiology, Johns Hopkins University, Baltimore, MD 21205, USA.

Experiments investigated maturation of endothelial function in the postnatal period. Carotid arteries isolated from newborn (postnatal day 1, P1) to P21 mice were assessed in myographs at transmural pressure (PTM) of 20 mmHg (P1 blood pressure, BP). Acetylcholine was ineffective in P1 but powerfully dilated P7 arteries, whereas NO-donor DEA-NONOate caused similar dilation at P1 and P7. Dilation to acetylcholine at P7 was abolished by inhibition of NO synthase (NOS) (l-NAME) or of phosphoinositide-3-kinase (PI3K) (wortmannin, LY294002). Endothelial NOS (eNOS) expression decreased in P7 compared with P1 arteries, although acetylcholine increased PO4-eNOS-Ser(1177) in P7 but not in P1 arteries. Endothelial maturation may therefore reflect increased signaling through PI3K, Akt, and eNOS. Systemic BP increases dramatically in the early postnatal period. After exposing P1 arteries to transient increased PTM (50 mmHg, 60 min), acetylcholine caused powerful dilation and increased PO4-eNOS-Ser(1177). Pressure-induced rescue of acetylcholine dilation was abolished by PI3K or NOS inhibition. Transient increased PTM did not affect dilation at P7, or dilation to NO-donor in P1 arteries. Width of endothelial adherens junctions (VE-cadherin immunofluorescence) increased significantly from P1 to P7, and in P1 arteries exposed to transient increased PTM. A function-blocking antibody to VE-cadherin reduced the pressure-induced rescue of acetylcholine responses at P1, and the dilation to acetylcholine in P7 arteries. Therefore, maturation of newborn endothelium dilator function may be induced by increasing BP in the postnatal period. Furthermore, this may be mediated by VE-cadherin signaling at adherens junctions. Interruption of this maturation pathway may contribute to developmental and adult vascular diseases.

UI MeSH Term Description Entries
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009213 Myography The recording of muscular movements. The apparatus is called a myograph, the record or tracing, a myogram. (From Stedman, 25th ed) Myographies
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D002339 Carotid Arteries Either of the two principal arteries on both sides of the neck that supply blood to the head and neck; each divides into two branches, the internal carotid artery and the external carotid artery. Arteries, Carotid,Artery, Carotid,Carotid Artery
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D005260 Female Females
D000081082 Phosphoinositide-3 Kinase Inhibitors Agents that inhibit PHOSPHOINOSITIDE-3 KINASE activity. Phosphoinositide-3 Kinase Inhibitor,Inhibitor, Phosphoinositide-3 Kinase,Inhibitors, Phosphoinositide-3 Kinase,Kinase Inhibitor, Phosphoinositide-3,Kinase Inhibitors, Phosphoinositide-3,Phosphoinositide 3 Kinase Inhibitor,Phosphoinositide 3 Kinase Inhibitors

Related Publications

Sheila Flavahan, and Mansoor M Mozayan, and Isa Lindgren, and Nicholas A Flavahan
February 2015, American journal of physiology. Heart and circulatory physiology,
Sheila Flavahan, and Mansoor M Mozayan, and Isa Lindgren, and Nicholas A Flavahan
February 2012, Journal of visualized experiments : JoVE,
Sheila Flavahan, and Mansoor M Mozayan, and Isa Lindgren, and Nicholas A Flavahan
October 1991, Circulation research,
Sheila Flavahan, and Mansoor M Mozayan, and Isa Lindgren, and Nicholas A Flavahan
July 1995, Pediatric research,
Sheila Flavahan, and Mansoor M Mozayan, and Isa Lindgren, and Nicholas A Flavahan
September 2016, The Journal of physiology,
Sheila Flavahan, and Mansoor M Mozayan, and Isa Lindgren, and Nicholas A Flavahan
October 2021, Journal of visualized experiments : JoVE,
Sheila Flavahan, and Mansoor M Mozayan, and Isa Lindgren, and Nicholas A Flavahan
October 1988, The American journal of physiology,
Sheila Flavahan, and Mansoor M Mozayan, and Isa Lindgren, and Nicholas A Flavahan
October 2004, Stroke,
Sheila Flavahan, and Mansoor M Mozayan, and Isa Lindgren, and Nicholas A Flavahan
May 1985, Heart and vessels,
Sheila Flavahan, and Mansoor M Mozayan, and Isa Lindgren, and Nicholas A Flavahan
November 2005, American journal of physiology. Heart and circulatory physiology,
Copied contents to your clipboard!